Impact of the "French Levothyrox crisis" on signal detection in the World Health Organization pharmacovigilance database

Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1427-1428. doi: 10.1002/pds.4682. Epub 2018 Oct 31.

Authors

Charles Khouri^{1

2

3}, Bruno Revol^{1

3}, Marion Lepelley¹, Michel Mallaret¹, Jean-Luc Cracowski^{2

3}

Affiliations

¹ Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France.
² Clinical Pharmacology Department, INSERM CIC1406, Grenoble Alpes University Hospital, Grenoble, France.
³ HP2 Laboratory, INSERM 1042, Grenoble Alpes University, Grenoble, France.

PMID: 30379373
DOI: 10.1002/pds.4682

No abstract available

Publication types

Letter

MeSH terms

Adverse Drug Reaction Reporting Systems / standards
Adverse Drug Reaction Reporting Systems / statistics & numerical data*
Alopecia / chemically induced
Alopecia / epidemiology
Bias
Data Interpretation, Statistical
Databases, Factual / statistics & numerical data
France
Guidelines as Topic
Humans
Pharmacovigilance*
Thyroxine / adverse effects*
World Health Organization*

Substances

Thyroxine